PH27056A - Ú5(6) (1H-azole-1-ylmethyl) benzimidazole - Google Patents

Ú5(6) (1H-azole-1-ylmethyl) benzimidazole Download PDF

Info

Publication number
PH27056A
PH27056A PH38181A PH38181A PH27056A PH 27056 A PH27056 A PH 27056A PH 38181 A PH38181 A PH 38181A PH 38181 A PH38181 A PH 38181A PH 27056 A PH27056 A PH 27056A
Authority
PH
Philippines
Prior art keywords
methyl
formula
parts
compound
helminths
Prior art date
Application number
PH38181A
Other languages
English (en)
Inventor
Alfons H M Raymaekers
Eddy J E Freyne
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PH27056A publication Critical patent/PH27056A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PH38181A 1988-02-12 1989-02-10 Ú5(6) (1H-azole-1-ylmethyl) benzimidazole PH27056A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/155,464 US4826862A (en) 1988-02-12 1988-02-12 Anthelminthic [(5(6) (1H-azole-1-ylmethyl)benzimidazole]carbamates

Publications (1)

Publication Number Publication Date
PH27056A true PH27056A (en) 1993-02-01

Family

ID=22555544

Family Applications (1)

Application Number Title Priority Date Filing Date
PH38181A PH27056A (en) 1988-02-12 1989-02-10 Ú5(6) (1H-azole-1-ylmethyl) benzimidazole

Country Status (17)

Country Link
US (1) US4826862A (ja)
EP (1) EP0328203A3 (ja)
JP (1) JPH01228986A (ja)
CN (1) CN1022245C (ja)
AU (1) AU605406B2 (ja)
DK (1) DK64089A (ja)
FI (1) FI890654A7 (ja)
IL (1) IL89249A (ja)
MA (1) MA21493A1 (ja)
MY (1) MY104979A (ja)
NO (1) NO172438C (ja)
NZ (1) NZ227801A (ja)
PH (1) PH27056A (ja)
PT (1) PT89659B (ja)
SU (1) SU1706389A3 (ja)
TN (1) TNSN89015A1 (ja)
ZA (1) ZA891079B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039677A (en) * 1987-06-01 1991-08-13 Janssen Pharmaceutica N.V. 6-(1H-azol-1-ylmethyl)-1-(pyrimidinyloxy)-1H benzotriazoles
US4943574A (en) * 1987-06-01 1990-07-24 Janssen Pharmaceutica N.V. (1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing them
US5072453A (en) * 1990-03-08 1991-12-17 Nathaniel Widder Body protection system
PH31175A (en) * 1990-10-31 1998-03-20 Squibb & Sons Inc Indole and benzimi-dazole-substituted imidazole and benzimidazole derivatives.
US5374615A (en) * 1990-10-31 1994-12-20 E. R. Squibb & Sons, Inc. Indole- and benzimidazole-substituted imidazole and benzimidazole derivatives
GB9115272D0 (en) * 1991-07-15 1991-08-28 Pfizer Ltd Benzimidazole anthelmintics
GB9115273D0 (en) * 1991-07-15 1991-08-28 Pfizer Ltd Benzimidazole anthelmintics
DE4142731A1 (de) * 1991-12-21 1993-06-24 Hoechst Ag Biozide polymerisate und polymerisatdispersionen, verfahren zu ihrer herstellung und ihre verwendung
GB9205368D0 (en) * 1992-03-12 1992-04-22 Pfizer Ltd Benzimidozole anthelmintic agents
US5278181A (en) * 1992-05-12 1994-01-11 Board Of Regents Acting On Behalf Of The University Of Michigan Soluble alkyl[5-[amino (phenyl)methyl]-1H-benzimidazol-2-yl] carbamate anthelmintics
GB9501737D0 (en) * 1994-04-25 1995-03-22 Hoffmann La Roche Hydroxamic acid derivatives
US20040170735A2 (en) * 2002-04-05 2004-09-02 Mcneil-Ppc, Inc. Methods and compositions for altering the sweetness delivery profile of sucralose
US20040086605A1 (en) * 2002-10-30 2004-05-06 Sox Thomas E. Composition for delivering a high intensity sweetener
US20040247014A1 (en) * 2003-05-02 2004-12-09 Vache John P Methods and apparatus for indicating temperature-related events

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935209A (en) * 1973-03-12 1976-01-27 Syntex (U.S.A.) Inc. 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
US3969526A (en) * 1973-05-29 1976-07-13 Smithkline Corporation Anthelmintic 5-heterocycliothio and oxy-2-carbalkoxyaminobenzimidazles
US4512998A (en) * 1980-10-20 1985-04-23 Schering Corporation Anthelmintic benzimidazole carbamates
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
EP0328203A2 (en) 1989-08-16
JPH01228986A (ja) 1989-09-12
CN1022245C (zh) 1993-09-29
US4826862A (en) 1989-05-02
DK64089A (da) 1989-08-13
NO890579L (no) 1989-08-14
CN1036014A (zh) 1989-10-04
FI890654A0 (fi) 1989-02-10
AU2966589A (en) 1989-08-17
PT89659B (pt) 1994-02-28
FI890654L (fi) 1989-08-13
MA21493A1 (fr) 1989-10-01
NO890579D0 (no) 1989-02-10
AU605406B2 (en) 1991-01-10
TNSN89015A1 (fr) 1991-02-04
MY104979A (en) 1994-07-30
NO172438B (no) 1993-04-13
PT89659A (pt) 1989-10-04
FI890654A7 (fi) 1989-08-13
NO172438C (no) 1993-07-21
SU1706389A3 (ru) 1992-01-15
DK64089D0 (da) 1989-02-10
IL89249A0 (en) 1989-09-10
EP0328203A3 (en) 1990-03-14
NZ227801A (en) 1990-10-26
IL89249A (en) 1993-03-15
ZA891079B (en) 1990-10-31

Similar Documents

Publication Publication Date Title
EP0006712B1 (en) Heterocyclic derivatives of (4-aryloxymethyl-1.3-dioxolan-2-yl) methyl-1h-imidazoles and -1h-1.2.4-triazoles, their preparation and the derivatives for use as fungicides and bactericides
CA1238321A (en) Anti-virally active pyridazinamines
AU653082B2 (en) Optically active azole compounds their production and use
FI87781B (fi) Foerfarande foer framstaellning av nya (1h-imidazol-1-ylmetyl)substituerade bensimidazolderivat
KR970000952B1 (ko) (1h-아졸-1-일메틸) 치환된 벤조트리아졸 유도체
PH27056A (en) Ú5(6) (1H-azole-1-ylmethyl) benzimidazole
EP0232937B1 (en) Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines
US4992433A (en) Novel pyridazinamine derivatives
US4835161A (en) Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines
IE65768B1 (en) Pyridizinamine derivatives
US5231184A (en) Pridazinamine derivatives
JP2988689B2 (ja) 抗真菌性の４−［４−［４−［４−［［２−（２，４−ジフルオロフェニル）−２−（１ｈ−アゾリルメチル）−１，３−ジオキソラン−４−イル］メトキシ］フェニル］−１−ピペラジニル］フェニル］トリアゾロン類およびイミダゾロン類
CZ415597A3 (cs) Triazolové sloučeniny, způsoby a meziprodukty pro jejich výrobu a farmaceutické prostředky na jejich bázi a jejich použití
JPS63238070A (ja) 複素環式化合物、その製造法及びこの化合物を含有しアロマターゼ抑制効果を有する製薬又は獣医薬組成物
US4943574A (en) (1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing them
JPH0649033A (ja) 光学活性アゾール化合物およびその用途
EP0142190B1 (en) 1-(2-aryl-2-halo-1-ethenyl)-1h-azoles
AU630431B2 (en) (5(6)-(benzisoxa-, benzisothia- or indazol-3-yl)-1H-benzimidazol-2-yl)carbamates
HU206343B (en) Process for producing 1,2-benzizoxazol- and 1,2-benzizothiazol derivatives and pharmaceutical compositions containing them
US5256681A (en) [5(6)-(benzisoxa-,benzisothia-or indazol-3-yl)-1H-benzimidazol-2-yl]carbamates
US5075309A (en) Antifungal 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]triazolones and imidazolones
WO1990010630A1 (en) [5(6)-(benzisoxa-, benzisothia- or indazol-3-yl)-1h-benzimidazol-2-yl] carbamates
US4533550A (en) Heterocyclic derivatives of (4-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US5039677A (en) 6-(1H-azol-1-ylmethyl)-1-(pyrimidinyloxy)-1H benzotriazoles
US20080293688A1 (en) Aminoazacyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands